Nonmalignant neoplasms of the lung are classified to code 212.3 for benign, 235.7 for uncertain behavior, and 239.1 for unspecified nature. If the lung cancer is considered a metastatic site—the cancer spread from another organ to the lung—code 197.0 is assigned.
Metastatic Lung Cancer ICD 9 Code Billable Medical Code for Malignant Neoplasm of Bronchus and Lung, Unspecified Diagnosis Code for Reimbursement Claim: ICD-9-CM 162.9
Billable Thru Sept 30/2015. Non-Billable On/After Oct 1/2015. Short description: Secondary malig neo lung. ICD-9-CM 197.0 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 197.0 should only be used for claims with a date of service on or before September 30, 2015.
162.9 is a legacy non-billable code used to specify a medical diagnosis of malignant neoplasm of bronchus and lung, unspecified. This code was replaced on September 30, …
2012 ICD-9-CM Diagnosis Code 162.9 Malignant neoplasm of bronchus and lung, unspecified Short description: Mal neo bronch/lung NOS. ICD-9-CM 162.9 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 162.9 should only be used for claims with a date of service on or before September 30, 2015.
162.9 is a legacy non-billable code used to specify a medical diagnosis of malignant neoplasm of bronchus and lung, unspecified. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
Doctors diagnose lung cancer using a physical exam, imaging, and lab tests. Treatment depends on the type, stage, and how advanced it is. Treatments include surgery, chemotherapy, radiation therapy, and targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.
Squamous cell carcinoma of lung, TNM stage 1. Squamous cell carcinoma of lung, TNM stage 2. Squamous cell carcinoma of lung, TNM stage 3. Squamous cell carcinoma of lung, TNM stage 4. T3: Lung tumor of any size in the main bronchus < 2 cm distal to the carina but without involvement of the carina.
T4: Lung tumor of any size with a malignant pleural effusion
Type 1 Excludes Notes - A type 1 Excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
NEC "Not elsewhere classifiable" - This abbreviation in the Alphabetic Index represents "other specified". When a specific code is not available for a condition, the Alphabetic Index directs the coder to the "other specified” code in the Tabular List.
Malignant neoplasm of bronchus and lung, unspecified 1 Short description: Mal neo bronch/lung NOS. 2 ICD-9-CM 162.9 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 162.9 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes). 3 You are viewing the 2012 version of ICD-9-CM 162.9. 4 More recent version (s) of ICD-9-CM 162.9: 2013 2014 2015.
Cancer of the lung, squamous cell, stage 1. Cancer of the lung, squamous cell, stage 2. Cancer of the lung, squamous cell, stage 3. Cancer of the lung, squamous cell, stage 4. Cancer of the right lung, large cell. Cancer of the right lung, squamous cell. Cancer, left lung. Cancer, lung, non small cell.
T3: Lung tumor of any size in the main bronchus < 2 cm distal to the carina but without involvement of the carina
This type of lung cancer is more common than small cell. Regardless of the cell type, the ICD-9-CM code for primary malignant neoplasm of the lung is 162.x, with the fourth-digit subcategory identifying the specified site of the cancer such as:
The biopsy may be performed though a bronchoscope (33.24), percutaneous needle (33.26), thoracoscopic (33.20), or open (33.28). A transthoracic needle biopsy of lung is also classified to code 33.26. Transbronchial lung biopsy (33.27) is when the bronchoscope biopsy forceps actually punctures the terminal bronchus and samples ...
There are two major types of lung cancer, which is determined by the appearance of the cancerous cells under a microscope: • Small-cell lung cancer: Also called oat cell cancer, it is the more aggressive type and frequently metastasizes to other sites such as the liver, bone, and brain.
The specific site of the lung biopsy (character 4) should be identified, including upper, middle, or lower lobe and the laterality of the biopsy (right vs. left vs. bilateral). The approach (character 5) may be one of the following:
Therefore, a thoracoscopic wedge biopsy of the left upper lung lobe is classified to ICD-10-PCS code 0BBG4ZX.
Vol. 23 No. 7 P. 27. Lung cancer is any type of malignant growth in the lungs that occurs when cells in the lung start to grow rapidly and uncontrollably. Smoking puts people at the highest risk of developing lung cancer, though exposure to secondhand smoke is also a major cause.
Carcinoma in situ of the lung is classified to code 231.2. Nonmalignant neoplasms of the lung are classified to code 212.3 for benign, 235.7 for uncertain behavior, and 239.1 for unspecified nature. If the lung cancer is considered a metastatic site—the cancer spread from another organ to the lung—code 197.0 is assigned.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C78.00 became effective on October 1, 2021.
If the documentation states the cancer is a metastatic cancer, but does not state the site of the metastasis, the coder will assign a code for the primary cancer, followed by code C79.9 secondary malignant neoplasm of unspecified site.
If the site of the primary cancer is not documented, the coder will assign a code for the metastasis first, followed by C80.1 malignant (primary) neoplasm, unspecified. For example, if the patient was being treated for metastatic bone cancer, but the primary malignancy site is not documented, assign C79.51, C80.1.
When coding malignant neoplasms, there are several coding guidelines we must follow:#N#To properly code a malign ant neoplasm, the coder must first determine from the documentation if the neoplasm is a primary malignancy or a metastatic (secondary) malignancy stemming from a primary cancer.
When a current cancer is no longer receiving treatment of any kind, it is coded as a history code. For instance, the patient had breast cancer (C50.xx) and underwent a mastectomy, followed by chemoradiation. The provider documents that the patient has no evidence of disease (NED).
For instance, a patient who has primary breast cancer (C50.xx) who is now seen for metastatic bone cancer will have a code for the secondary bone cancer (C79.51) sequenced before a code for the primary breast cancer (C50.xx). When a current cancer is no longer receiving treatment of any kind, it is coded as a history code.